[1] Roehlen N, Crouchet E, Baumert TF. Liver fibrosis:Mechanistic concepts and therapeutic perspectives. Cells, 2020, 9(4):875-878. [2] Le Bert N, Gill US, Hong M, et al. Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection. Gastroenterology, 2020, 159(2):652-664. [3] Manka P, Zeller A, Syn WK. Fibrosis in chronic liver disease: An update on diagnostic and treatment modalities. Drugs, 2019, 79(9):903-927. [4] Lambrecht J, Van Grunsven LA, Tacke F. Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis. Expert Opin Pharmacother, 2020, 21(13):1637-1650. [5] Ostankova YV, Semenov AV, Totolian AA. The quantitative determination method of covalently closed circular DNA HBV in puncture biopsy specimens of the liver. Klin Lab Diagn, 2019, 64(9):565-570. [6] Caillol F, Rouy M, Pesenti C, et al. Drainage of the right liver using EUS guidance. Endosc Ultrasound, 2019, 8(1):50-56. [7] 魏倩, 赵林, 付宁, 等. 彩色多普勒超声检查早期诊断乙型肝炎肝硬化价值研究. 实用肝脏病杂志, 2019, 22(3):116-119. [8] Nakatsuka T, Soroida Y, Nakagawa H, et al. Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation. Hepatol Res, 2019, 49(3):304-313. [9] Soroida Y, Nakatsuka T, Sato M, et al. A novel non-invasive method forpredicting liver fibrosis by quantifying the hepatic vein waveform. Ultrasound Med Biol, 2019, 45(9):2363-2371. [10] Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol, 2021, 18(3):151-166. [11] Shen WJ, Chen G, Wang M, et al. Liver fibrosis in biliary atresia. World J Pediatr, 2019, 15(2):117-123. [12] Mohan BP, Shakhatreh M, Garg R, et al. Efficacy and safety of EUS-guided liver biopsy: a systematic review and meta-analysis. Gastrointest Endosc, 2019, 89(2):238-246. [13] Kaniyev S, Baimakhanov Z, Doskhanov M, et al. Recent treatment results of liver echinococcosis by pair method. Georgian Med News, 2020, 11(308):11-14. [14] Beyazal M, Beyazal Polat H, Erturk A, et al. Noninvasive assessment of liver parenchyma using gray-scale ultrasound-based histogram analysis in patients with chronic hepatitis B infection. Ultrasound Q, 2020, 36(1):69-73. [15] Gulbay M, Ciliz DS, Celikbas AK, et al. Intravoxel incoherent motion parameters inthe evaluation of chronic hepatitis B virus-induced hepatic injury: fibrosis and capillarity changes. Abdom Radiol, 2020, 45(8):2345-2357. [16] Clarke W T, Miranda J, Neidich E, et al. Metabolic syndrome and liver steatosis occur at lower body mass indexin US Asian patients with chronic hepatitis B. J Viral Hepat, 2019, 26(10):1164-1169. [17] 中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版). 中华肝脏病杂志, 2019, 27(7):494-504. [18] Agbim U, Asrani SK. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Rev Gastroenterol Hepatol, 2019, 13(4):361-374. [19] Smid V. Liver fibrosis. Vnitr Lek, 2020, 66(4):61-66. [20] Lyu C, Lopez-Ichikawa M, Rubinsky B, et al. Normal and fibrotic liver parenchyma respond differently to irreversible electroporation. HPB, 2019, 21(10):1344-1353. |